Investor mix
10 investors on record; lead investors include Canaan, 6 Dimensions Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Angel & family office | 2 | 20% |
| Other / undisclosed | 1 | 10% |
Developer of antiviral therapeutics for the treatment of chronic HBV infections
10 investors on record; lead investors include Canaan, 6 Dimensions Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Angel & family office | 2 | 20% |
| Other / undisclosed | 1 | 10% |